EN
HI
Bliss GVS Pharma Chart
Bliss GVS Pharma Share Key Metrics
Volume
6.19 L
Market Cap
4460.06 CR
LTQ@LTP
10@421.60
ATP
421.68
Var Margin
100 %
Circuit Range
377.65-461.55
Delivery %
38.62 %
Value
26.09 CR
ASM/GSM
No
Market Lot
1
Summary
Bliss GVS Pharma share price is ₹421.6 as of 10 Jun, 2026. The stock Bliss GVS Pharma intraday movement has stayed between ₹415.60 and ₹428.75, while on a 52-week basis,Bliss GVS Pharma price 52 week high is ₹462.80 & its 52 week low is ₹118.00.
In terms of trading activity, Bliss GVS Pharma has recorded a volume of 618672 shares, The Bliss GVS Pharma has a market cap of ₹105788972 CR. The stock’s Average Traded Price (ATP) stands at ₹421.68, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹421.60.
Bliss GVS Pharma operates within a circuit range of ₹377.65 – ₹461.55, with a Value of ₹26.09 CR. The Delivery Percentage for the day is 38.62%. Additionally, Bliss GVS Pharma currently falls under the No framework, and trades with a market lot size of 1.
Bliss GVS Pharma Fundamentals
P/E Ratio
34.34
P/B Ratio
3.72
Div. Yield
0.24
Sector P/E
67.41
Sector P/B
2.96
Sec. Div. Yield
0.54
Bliss GVS Pharma Resistance and Support
Pivot 428.13
Resistance
First Resistance
438.96
Second Resistance
458.33
Third Resistance
469.16
Support
First Support
408.76
Second Support
397.93
Third Support
378.56
Bliss GVS Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-12 | Audited Results & Final Dividend |
| 2026-02-10 | Quarterly Results & Interim Dividend |
| 2025-11-06 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results & Others |
Bliss GVS Pharma News
Bliss GVS Pharma Ltd - 506197 - Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Bliss GVS Pharma informed about the filing of a draft letter of offer for a mandatory open offer by Anupam Rasayan India Limited. The offer is to acquire up to 26.00% of the company's expanded voting share capital at an offer price of Rs. 299.00 per share, with a total consideration of approximately Rs. 829 crore, triggered by an acquisition for control.
Jun 09 2026 19:27:05
Bliss GVS Pharma Ltd - 506197 - Draft Letter of Offer
Anupam Rasayan India Limited (Acquirer) announced a mandatory open offer to acquire up to 26.00% of Bliss GVS Pharma's expanded voting share capital from public shareholders at Rs.299 per equity share. The total consideration for this offer, assuming full acceptance, is Rs.829.03 crore. The tendering period for the offer will be from July 16, 2026, to July 29, 2026.
Jun 09 2026 10:19:37
Read More
Bliss GVS Pharma Management
| Name | Position |
|---|---|
| Aditi Bhatt | Company Secretary & Compliance Officer |
| Nandkumar chodankar | Chairman |
Bliss GVS Pharma Similar Stocks
Aarti Pharmalabs Ltd.
625.25
18.90 (3.12%)
Supriya Lifescience Ltd.
962.90
43.80 (4.77%)
Innova Captab Ltd.
914.70
44.65 (5.13%)
Senores Pharmaceuticals Ltd.
1094.50
87.50 (8.69%)
Orchid Pharma Ltd.
859.80
17.25 (2.05%)
Artemis Medicare Services Ltd.
258.15
0.40 (0.16%)
Advanced Enzyme Technologies Ltd.
372.15
0.15 (0.04%)
IOL Chemicals And Pharmaceuticals Ltd.
132.84
5.92 (4.66%)
Indraprastha Medical Corporation Ltd.
393.80
4.15 (1.07%)
Bliss GVS Pharma FAQs
The Buying Price of Bliss GVS Pharma share is 421.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bliss GVS Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bliss GVS Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bliss GVS Pharma shares is 34.34. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bliss GVS Pharma shares is 3.72. Useful to assess the stock's value relative to its book value.
To assess Bliss GVS Pharma’s valuation compare Sector P/E, P/B which are 67.41 & 2.96 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bliss GVS Pharma is 4460.06 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bliss GVS Pharma share price is 462.80 & 118.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bliss GVS Pharma belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
